Dyadic DYAI Stock
Dyadic Price Chart
Dyadic DYAI Financial and Trading Overview
| Dyadic stock price | 1.26 USD |
| Previous Close | 1.02 USD |
| Open | 1.03 USD |
| Bid | 0.79 USD x 200 |
| Ask | 1.33 USD x 200 |
| Day's Range | 1.01 - 1.1 USD |
| 52 Week Range | 0.65 - 1.35 USD |
| Volume | 42.36K USD |
| Avg. Volume | 296.45K USD |
| Market Cap | 39.73M USD |
| Beta (5Y Monthly) | 1.145 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.21 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6 USD |
DYAI Valuation Measures
| Enterprise Value | 36.61M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.4071875 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 10.433808 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 9.615 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Dyadic Stock Price History
| Beta (5Y Monthly) | 1.145 |
| 52-Week Change | 4.08% |
| S&P500 52-Week Change | 20.36% |
| 52 Week High | 1.35 USD |
| 52 Week Low | 0.65 USD |
| 50-Day Moving Average | 0.79 USD |
| 200-Day Moving Average | 0.89 USD |
DYAI Share Statistics
| Avg. Volume (3 month) | 296.45K USD |
| Avg. Daily Volume (10-Days) | 252.29K USD |
| Shares Outstanding | 36.44M |
| Float | 27.37M |
| Short Ratio | 0.9 |
| % Held by Insiders | 25.53% |
| % Held by Institutions | 14.96% |
| Shares Short | 174.71K |
| Short % of Float | 0.57% |
| Short % of Shares Outstanding | 0.47% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -191.49% |
| Operating Margin (ttm) | -172.12% |
| Gross Margin | 26.09% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -56.21% |
| Return on Equity (ttm) | -2826.92% |
Income Statement
| Revenue (ttm) | 3.81M USD |
| Revenue Per Share (ttm) | 0.11 USD |
| Quarterly Revenue Growth (yoy) | 182.29% |
| Gross Profit (ttm) | 993.69K USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -7291732 USD |
| Diluted EPS (ttm) | -0.21 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.61M USD |
| Total Cash Per Share (mrq) | 0.15 USD |
| Total Debt (mrq) | 5.05M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.418 |
| Book Value Per Share (mrq) | -0.011 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5715824 USD |
| Levered Free Cash Flow (ttm) | -4185846 USD |
Profile of Dyadic
| Country | United States |
| State | FL |
| City | Jupiter |
| Address | 1044 North U.S. Highway One |
| ZIP | 33477-5094 |
| Phone | 561 743 8333 |
| Website | https://www.dyadic.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 5 |
Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases; and collaboration with Scripps Research to evaluate monoclonal antibody and vaccine candidates targeting hantaviruses. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
Q&A For Dyadic Stock
What is a current DYAI stock price?
Dyadic DYAI stock price today per share is 1.26 USD.
How to purchase Dyadic stock?
You can buy DYAI shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Dyadic?
The stock symbol or ticker of Dyadic is DYAI.
Which industry does the Dyadic company belong to?
The Dyadic industry is Biotechnology.
How many shares does Dyadic have in circulation?
The max supply of Dyadic shares is 36.44M.
What is Dyadic Price to Earnings Ratio (PE Ratio)?
Dyadic PE Ratio is now.
What was Dyadic earnings per share over the trailing 12 months (TTM)?
Dyadic EPS is -0.21 USD over the trailing 12 months.
Which sector does the Dyadic company belong to?
The Dyadic sector is Healthcare.
Dyadic DYAI included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26231.38 USD — |
+0.48
|
1.1B USD — | 26177.52 USD — | 26313.46 USD — | — - | 1.1B USD — |
|
US Tech Capital Market Composite
RCMP
US
|
140.87 USD — |
+0.41
|
— — | 139.95 USD — | 141.42 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1241.67 USD — |
+0.03
|
— — | 1233.72 USD — | 1242.16 USD — | — - | — — |
- {{ link.label }} {{link}}